ImaginAb is excited to announce the availability of clinical grade 89Zr-Oxine for ex vivo labeling of cell-based products.
Cell labeling with 89Zr-Oxine enables subsequent in vivo monitoring of the biodistribution of cell-based products using standard PET cameras and labeling does not affect cell function. The labeling process is simple and can be done at most clinical sites.
89Zr-Oxine cell labeling can support clinical development by allowing:
ImaginAb is ready to ship both pre-clinical and GMP material directly to research or clinical sites in the United States.
For more information about enhancing the development of your cell-based products with 89Zr-Oxine cell labeling, contact: email@example.com